Fenfen Li

Dr. Fenfen Li


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MXMengran Xu
Mengran Xu
YHYi Hu
Yi Hu
YXYa Xiao
Ya Xiao
YZYuanyuan Zhang
Yuanyuan Zhang
KSKaili Sun
Kaili Sun
JLJiabin Li
Jiabin Li

25 March 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Qurat ul Ain ZahraQurat ul Ain Zahra
Qurat ul Ain Zahra
ZLZhaofeng Luo
Zhaofeng Luo
Rizwan AliRizwan Ali
Rizwan Ali
MKMuhammad Imran Khan
Muhammad Imran Khan
FLFenfen Li
Fenfen Li
BQBensheng Qiu
Bensheng Qiu
Misuse of antibiotics has recently been considered a global issue because of its harmful effects on human health. Since conventional methods have numerous limitations, it is necessary to develop fast, simple, sensitive, and reproducible methods for the detection of antibiotics. Among numerous recently developed methods, aptasensors are fascinating because of their good specificity, sensitivity and selectivity. These kinds of biosensors combining aptamer with colorimetric applications of gold nanoparticles to recognize small molecules are becoming more popular owing to their advantageous features, for example, low cost, ease of use, on-site analysis ability using naked eye and no prerequisite for modern equipment. In this review, we have highlighted the recent advances and working principle of gold nanoparticles based colorimetric aptasensors as promising methods for antibiotics detection in different food and environmental samples (2011–2020). Furthermore, possible advantages and disadvantages have also been summarized for these methods. Finally, the recent challenges, outlook, and promising future perspectives for developing novel aptasensors are also considered.

1 June 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XHXiao Lin Huang
Xiao Lin Huang
MKMuhammad Imran Khan
Muhammad Imran Khan
JWJing Wang
Jing Wang
Rizwan AliRizwan Ali
Rizwan Ali
SASyed Wajahat Ali
Syed Wajahat Ali
BQBensheng Qiu
Bensheng Qiu

6 July 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SYShengnan Ya
Shengnan Ya
Weiping DingWeiping Ding
Weiping Ding
SLShibo Li
Shibo Li
KDKun Du
Kun Du
YZYuanyuan Zhang
Yuanyuan Zhang
BQBensheng Qiu
Bensheng Qiu

12 May 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
FYFan Yu
Fan Yu
YZYuanyuan Zhang
Yuanyuan Zhang
CYChen Yang
Chen Yang
FLFenfen Li
Fenfen Li
BQBensheng Qiu
Bensheng Qiu
Weiping DingWeiping Ding
Weiping Ding
Psoriasis is one of the most influential and fastest-growing inflammatory diseases of the skin. Curcumin (CRC) is an effective antipsoriatic drug that is often carried by nanoparticles or liposomes mainly administered via the skin. However, the therapeutic effectiveness and bioavailability of this drug are restricted due to the functions of the skin barrier to liposomes. Herein, we proposed a peptide-modified curcumin-loaded liposome (CRC–TD–Lip) to expedite the transdermal delivery of curcumin and enhance the inhibition of psoriasis. CRC–TD–Lip was prepared and dispersed uniformly with high stability and high curcumin encapsulation efficiency. We confirmed the improved intracellular uptake of CRC–TD–Lip, the increased inhibitory effect of CRC–TD–Lip on HaCaT cells, and the heightened transdermal ability of CRC–TD–Lip. Then, the enhanced antipsoriatic ability of CRC–TD–Lip was evaluated in vivo using an imiquimod-induced psoriasis mouse model. The results indicated that the developed CRC–TD–Lip can effectively improve the delivery of curcumin across the skin and enhance the antipsoriasis efficiency. This work can provide a strategy for enhancing the transdermal delivery efficiency of drugs for various skin diseases.

1 January 2020 in Journal of Radiation Research and Applied Sciences
Verified
Journal Article
Open access
MKMuhammad Imran Khan
Muhammad Imran Khan
SXSurui Xu
Surui Xu
MAMalik Mubashar Ali
Malik Mubashar Ali
Rizwan AliRizwan Ali
Rizwan Ali
AKAhsan Kazmi
Ahsan Kazmi
FLFenfen Li
Fenfen Li
The emerging threat of multi-drug resistance (MDR) in a wide range of diseases is a major public health problem, which prolongs treatment, imposes disabilities and reduces the expected life span. MDR is common in urinary tract infections (UTI). Due to recent dramatic change in antimicrobial activity spectrum, we evaluated the current spectrum of antimicrobials activity in UTIs. We observed 33% infection rate in cultures and positive cultures were followed by the Kirby–Bauer technique for sensitivity testing. We evaluated that females are 3.71 folds more infected than males. We observed Escherichia coli (E. coli) as the most frequent and Pseudomonas aeruginosa (P. aeruginosa) as the least (9.1%). Further, we noted that E. coli infection in males is 4.75 times of males. Moreover, Klebsiella pneumoniae (K. pneumoniae) and E. coli are 2.33 and 7.67 times more prevalent than P. aeruginosa respectively. Our sensitivity results indicate that E. coli and K. pneumoniae are resistant to the most tested antimicrobials. However, P. aeruginosa is susceptible to only few of the tested drugs which include Amikacin, Piperacillin+Tazobactam (in combination), and Ceftriaxone. We conclude, due to MDR strains we need to imitate the current strategies and propose neoadjuvant and other therapies like applied in cancer.